| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2008 | WO2008006040A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006039A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006032A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006025A1 Dihydrofuro pyrimidines as akt protein kinase inhibitors |
| 01/10/2008 | WO2008006021A2 Shifter with actuator incorporating shape memory alloy |
| 01/10/2008 | WO2008005964A2 Phosphonate and phosphinate compounds as glucokinase activators |
| 01/10/2008 | WO2008005956A2 Pyrrolotriazine kinase inhibitors |
| 01/10/2008 | WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 01/10/2008 | WO2008005937A2 Treatment of neurodegenerative diseases through inhibiton of hsp90 |
| 01/10/2008 | WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 01/10/2008 | WO2008005908A2 Pyridoimidazole derivatives |
| 01/10/2008 | WO2008005877A2 Inhibitors of c-kit and uses thereof |
| 01/10/2008 | WO2008005824A1 Adjuvants and methods of use |
| 01/10/2008 | WO2008005819A2 Ophthalmic formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/10/2008 | WO2008005818A1 Glyceride esters for the treatment of diseases associated with reduced neuronal metabolism of glucose |
| 01/10/2008 | WO2008005806A2 Therapeutic methods, compositions, and compounds |
| 01/10/2008 | WO2008005802A2 Nasal formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 01/10/2008 | WO2008005742A2 Ibuprofen-containing liquid filled hard capsules |
| 01/10/2008 | WO2008005692A2 INHALANT FORMULATION CONTAINING SULFOALKYL ETHER γ-CYCLODEXTRIN AND CORTICOSTEROID |
| 01/10/2008 | WO2008005691A1 Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| 01/10/2008 | WO2008005634A1 Absorbable cyanoacrylate compositions |
| 01/10/2008 | WO2008005580A2 Formulation for treatment of acne |
| 01/10/2008 | WO2008005576A1 Modulators of metabolism and the treatment of disorders related thereto |
| 01/10/2008 | WO2008005572A2 Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof |
| 01/10/2008 | WO2008005570A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/10/2008 | WO2008005565A2 Antiviral phosphinate compounds |
| 01/10/2008 | WO2008005560A2 Prevention of thrombotic disorders with active vitamin d compounds |
| 01/10/2008 | WO2008005555A1 Modulators of toll-like receptor 7 |
| 01/10/2008 | WO2008005543A2 Compositions with controlled pharmacokinetics |
| 01/10/2008 | WO2008005542A2 Antiviral phosphinate compounds |
| 01/10/2008 | WO2008005534A2 Orally dissolving formulations of memantine |
| 01/10/2008 | WO2008005511A2 Novel inhibitors of hepatitis c virus replication |
| 01/10/2008 | WO2008005479A2 Charge reversible polymers |
| 01/10/2008 | WO2008005471A2 Novel heterobicyclic compounds |
| 01/10/2008 | WO2008005457A2 Pyridinonyl pdk1 inhibitors |
| 01/10/2008 | WO2008005451A2 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | WO2008005407A2 Trace amine-associated receptors in the olfactory epithelium |
| 01/10/2008 | WO2008005368A2 Piperazines as p2x7 antagonists |
| 01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | WO2008005345A2 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions |
| 01/10/2008 | WO2008005338A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2008005333A2 Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females |
| 01/10/2008 | WO2008005303A2 Thiazolopyrimidine modulators of trpv1 |
| 01/10/2008 | WO2008005295A2 Modulators of muscarinic receptors |
| 01/10/2008 | WO2008005287A1 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/10/2008 | WO2008005277A1 Everolimus/pimecrolimus-eluting implantable medical devices |
| 01/10/2008 | WO2008005268A1 Substituted piperidines that increase p53 activity and the uses thereof |
| 01/10/2008 | WO2008005267A2 Sugar-free storage-stable antihistaminic syrups |
| 01/10/2008 | WO2008005262A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | WO2008005240A2 Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof |
| 01/10/2008 | WO2008005217A2 Iron(ii)-containing treatments for hyperphosphatemia |
| 01/10/2008 | WO2008005084A2 Methods to prevent and treat diseases |
| 01/10/2008 | WO2008005059A2 Treatment of mouth and urinary tract infections |
| 01/10/2008 | WO2008005039A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/10/2008 | WO2008005036A1 Pharmaceutical compositions of memantine |
| 01/10/2008 | WO2008005033A1 Infant formulas for early brain development |
| 01/10/2008 | WO2008005019A1 Compositions and methods for the treatment of muscle wasting |
| 01/10/2008 | WO2008005002A1 Compositions and methods for the treatment of muscle wasting |
| 01/10/2008 | WO2008004948A1 8-oxoadenine derivatives acting as modulators of tlr7 |
| 01/10/2008 | WO2008004946A1 New pyridine analogues |
| 01/10/2008 | WO2008004945A1 Novel crystalline forms i and ii |
| 01/10/2008 | WO2008004944A1 Novel crystalline form ii |
| 01/10/2008 | WO2008004943A1 New pyridine analogues |
| 01/10/2008 | WO2008004942A1 New pyridine analogues |
| 01/10/2008 | WO2008004941A1 New pyridine analogues |
| 01/10/2008 | WO2008004908A1 Nootropic medicinal agent |
| 01/10/2008 | WO2008004900A1 Production of ultrapure epa and polar lipids from largely heterotrophic culture |
| 01/10/2008 | WO2008004847A1 Photosensitizer containing indole-3-alkylcarboxylic acid, and kit for photodynamic therapy containing the same |
| 01/10/2008 | WO2008004836A1 Triazine derivative compound and composition for treating cancer containing them |
| 01/10/2008 | WO2008004716A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 01/10/2008 | WO2008004698A2 Pyrazolo [1, 5-a] pyrimidine compounds as cb1 receptor antagonist |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004653A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | WO2008004610A1 Method of treating genetic disease caused by nonsense mutation |
| 01/10/2008 | WO2008004542A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 01/10/2008 | WO2008004341A1 α-SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES |
| 01/10/2008 | WO2008004340A1 Senescence inhibitor |
| 01/10/2008 | WO2008004333A1 Agent for improving muscle power |
| 01/10/2008 | WO2008004231A1 Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 01/10/2008 | WO2008004224A2 Synergistic compositions for crohn's disease and inflammatory gastrointestinal disorders |
| 01/10/2008 | WO2008004223A2 Compounds and methods for the treatment of menopause and bone related disorders |
| 01/10/2008 | WO2008004191A2 Process for the preparation of enantiomerically pure salts of n-methyl-3- ( 1-naphthaleneoxy) -3- (2-thienyl) propanamine |
| 01/10/2008 | WO2008004117A1 Selective azole pde10a inhibitor compounds |
| 01/10/2008 | WO2008004096A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 01/10/2008 | WO2008004067A2 Alpha-2-delta-1 selective compounds for disorders of the nervous system |
| 01/10/2008 | WO2008004033A1 A stable olanzapine formulation with antioxidants |
| 01/10/2008 | WO2008004013A2 Medicament for the enhancement of cognitive function and neuroprotection |
| 01/10/2008 | WO2008003978A2 Dioxo-alkanes and dioxo-alkenes |
| 01/10/2008 | WO2008003864A1 Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins |
| 01/10/2008 | WO2008003861A1 Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 01/10/2008 | WO2008003857A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 01/10/2008 | WO2008003856A1 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | WO2008003855A2 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | WO2008003809A1 Antitumour compounds |
| 01/10/2008 | WO2008003770A1 Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents |
| 01/10/2008 | WO2008003769A2 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 01/10/2008 | WO2008003753A1 Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity |
| 01/10/2008 | WO2008003752A1 2 -amino benzimidazole derivatives and their use as modulators of small - conductance calcium -act ivated potassium channels |
| 01/10/2008 | WO2008003736A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 01/10/2008 | WO2008003697A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |